This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thillainadesan, G.
Right arrow Articles by Torchia, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thillainadesan, G.
Right arrow Articles by Torchia, J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 2008, p. 6066-6077, Vol. 28, No. 19
0270-7306/08/$08.00+0     doi:10.1128/MCB.00246-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Genome Analysis Identifies the p15ink4b Tumor Suppressor as a Direct Target of the ZNF217/CoREST Complex{triangledown} ,{dagger}

Gobi Thillainadesan,1,2 Majdina Isovic,1 Esther Loney,1 Joseph Andrews,1 Marc Tini,3 and Joseph Torchia1,2*

Department of Oncology,1 London Regional Cancer Program and The Lawson Health Research Institute, Department of Biochemistry,2 Department of Physiology and Pharmacology, The University of Western Ontario, London, Ontario, Canada3

Received 13 February 2008/ Returned for modification 12 March 2008/ Accepted 4 July 2008

The ZNF217 oncoprotein is a constituent of a core transcriptional complex that includes CoREST, histone deacetylase 1/2, lysine demethylase 1, and the C-terminal binding protein 1/2. We have combined genome-wide expression profiling and chromatin immunoprecipitation with directed selection and ligation (ChIP-DSL) to identify a subset of genes directly regulated by ZNF217. Our results establish p15ink4b as a direct target of the ZNF217 complex. Downregulation of ZNF217 in MCF-7 breast cancer cells resulted in a dramatic increase in p15ink4b expression and coincided with increases in dimethylation of H3-K4 and, surprisingly, a decrease in K9/K14-H3 acetylation. Stimulation of HaCaT cells with transforming growth factor β (TGF-β) resulted in a release of ZNF217 and a concomitant binding of SMAD2 to the proximal promoter, which preceded increases in ink4b protein expression. Furthermore, the changes in chromatin marks at the p15ink4b promoter following TGF-β stimulation were similar to those observed following ZNF217 downregulation. Collectively, these results establish the ZNF217 complex as a novel negative regulator of the p15ink4b gene and may constitute an important link between amplification of ZNF217 and the loss of TGF-β responsiveness in breast cancer.

* Corresponding author. Mailing address: Cancer Research Laboratories, London Regional Cancer Program, London, Ontario, Canada N6A 4L6. Phone: (519) 685-8692. Fax: (519) 685-8673. E-mail: jtorchia{at}uwo.ca

{triangledown} Published ahead of print on 14 July 2008.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.

Molecular and Cellular Biology, October 2008, p. 6066-6077, Vol. 28, No. 19
0270-7306/08/$08.00+0     doi:10.1128/MCB.00246-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Chinnadurai, G. (2009). The Transcriptional Corepressor CtBP: A Foe of Multiple Tumor Suppressors. Cancer Res. 69: 731-734 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»